-+ 0.00%
-+ 0.00%
-+ 0.00%

CUMBERLAND PHARMACEUTICALS RECEIVES FDA FAST TRACK DESIGNATION FOR ITS IFETROBAN DUCHENNE MUSCULAR DYSTROPHY PROGRAM

Reuters·02/04/2026 14:05:01

Please log in to view news